Dr. William V. Walsh
Claim this profileUMass Memorial Medical Center - University Campus
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
19 reported clinical trials
34 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials William V. Walsh is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about William V. Walsh
Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments William V. Walsh has experience with
- Pembrolizumab
- Carboplatin
- Cisplatin
- Bevacizumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
Breakdown of trials William V. Walsh has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William V. Walsh specialize in?
William V. Walsh focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is William V. Walsh currently recruiting for clinical trials?
Yes, William V. Walsh is currently recruiting for 8 clinical trials in Worcester Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that William V. Walsh has studied deeply?
Yes, William V. Walsh has studied treatments such as Pembrolizumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with William V. Walsh?
Apply for one of the trials that William V. Walsh is conducting.
What is the office address of William V. Walsh?
The office of William V. Walsh is located at: UMass Memorial Medical Center - University Campus, Worcester, Massachusetts 01655 United States. This is the address for their practice at the UMass Memorial Medical Center - University Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.